Use of human tissue to assess the oncogenic activity of melanoma-associated mutations (original) (raw)

References

  1. Gilchrest, B.A., Eller, M.S., Geller, A.C. & Yaar, M. The pathogenesis of melanoma induced by ultraviolet radiation. N. Engl. J. Med. 340, 1341–1348 (1999).
    Article CAS Google Scholar
  2. Schaffer, J.V., Rigel, D.S., Kopf, A.W. & Bolognia, J.L. Cutaneous melanoma–past, present, and future. J. Am. Acad. Dermatol. 51, S65–S69 (2004).
    Article Google Scholar
  3. Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949–954 (2002).
    Article CAS Google Scholar
  4. Pollock, P.M. et al. High frequency of BRAF mutations in nevi. Nat. Genet. 33, 19–20 (2003).
    Article CAS Google Scholar
  5. Rodolfo, M., Daniotti, M. & Vallacchi, V. Genetic progression of metastatic melanoma. Cancer Lett. 214, 133–147 (2004).
    Article CAS Google Scholar
  6. Tsao, H., Goel, V., Wu, H., Yang, G. & Haluska, F.G. Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma. J. Invest. Dermatol. 122, 337–341 (2004).
    Article CAS Google Scholar
  7. Wu, H., Goel, V. & Haluska, F.G. PTEN signaling pathways in melanoma. Oncogene 22, 3113–3122 (2003).
    Article CAS Google Scholar
  8. Stahl, J.M. et al. Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res. 64, 7002–7010 (2004).
    Article CAS Google Scholar
  9. Kamb, A. et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat. Genet. 8, 23–26 (1994).
    Article CAS Google Scholar
  10. Hussussian, C.J. et al. Germline p16 mutations in familial melanoma. Nat. Genet. 8, 15–21 (1994).
    Article CAS Google Scholar
  11. Hayward, N.K. Genetics of melanoma predisposition. Oncogene 22, 3053–3062 (2003).
    Article CAS Google Scholar
  12. Wolfel, T. et al. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269, 1281–1284 (1995).
    Article CAS Google Scholar
  13. Albino, A.P. et al. Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res. 4, 35–45 (1994).
    Article CAS Google Scholar
  14. Weitzman, J.B. & Yaniv, M. Rebuilding the road to cancer. Nature 400, 401–402 (1999).
    Article CAS Google Scholar
  15. Hamad, N.M. et al. Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev. 16, 2045–2057 (2002).
    Article CAS Google Scholar
  16. Nishimura, E.K. et al. Dominant role of the niche in melanocyte stem-cell fate determination. Nature 416, 854–860 (2002).
    Article CAS Google Scholar
  17. Sharpless, N.E., Kannan, K., Xu, J., Bosenberg, M.W. & Chin, L. Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo. Oncogene 22, 5055–5059 (2003).
    Article CAS Google Scholar
  18. Kannan, K. et al. Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model. Proc. Natl. Acad. Sci. USA 100, 1221–1225 (2003).
    Article CAS Google Scholar
  19. Beer, S. et al. Developmental context determines latency of MYC-induced tumorigenesis. PLoS Biol. 2, e332 (2004).
    Article Google Scholar
  20. Dajee, M. et al. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421, 639–643 (2003).
    Article CAS Google Scholar
  21. Lazarov, M. et al. CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis. Nat. Med. 8, 1105–1114 (2002).
    Article CAS Google Scholar
  22. Clark, E.A., Golub, T.R., Lander, E.S. & Hynes, R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532–535 (2000).
    Article CAS Google Scholar
  23. Brookes, S., Rowe, J., Gutierrez Del Arroyo, A., Bond, J. & Peters, G. Contribution of p16(INK4a) to replicative senescence of human fibroblasts. Exp. Cell Res. 298, 549–559 (2004).
    Article CAS Google Scholar
  24. Randerson-Moor, J.A. et al. A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum. Mol. Genet. 10, 55–62 (2001).
    Article CAS Google Scholar
  25. Stewart, S.A. et al. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc. Natl. Acad. Sci. USA 99, 12606–12611 (2002).
    Article CAS Google Scholar
  26. Chang, S. & DePinho, R.A. Telomerase extracurricular activities. Proc. Natl. Acad. Sci. USA 99, 12520–12522 (2002).
    Article CAS Google Scholar
  27. Kinsella, T.M. & Nolan, G.P. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7, 1405–1413 (1996).
    Article CAS Google Scholar
  28. Deng, H., Choate, K.A., Lin, Q. & Khavari, P.A. High efficiency gene transfer and pharmacologic selection of genetically engineered human keratinocytes. Biotechniques 25, 274–280 (1998).
    Article CAS Google Scholar
  29. Hsu, M., Andl, T., Li, G., Meinkoth, J.L. & Herlyn, M. Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J. Cell Sci. 113, 1535–1542 (2000).
    CAS PubMed Google Scholar
  30. Kern, S.E. et al. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256, 827–830 (1992).
    Article CAS Google Scholar

Download references